Data Science

Can RWE Fulfill Its Post-Pandemic Promise?
Data and Information Can RWE Fulfill Its Post-Pandemic Promise?

The rapid development of a novel vaccine in under a year, a feat that once seemed impossible within traditional research timelines, permanently altered the landscape of pharmaceutical innovation. This monumental achievement was not just a scientific breakthrough; it was a powerful proof-of-concept

Transforming Health Data Into a Strategic Asset
Data and Information Transforming Health Data Into a Strategic Asset

The vast digital universe of healthcare, now exceeding 65 zettabytes of information, presents a profound contradiction where an astonishing 97% of this data remains untapped, leaving its immense potential for clinical and operational improvement locked away. This discrepancy marks the central

Is There a Roadmap to Healthcare Excellence?
Process Is There a Roadmap to Healthcare Excellence?

The relentless pursuit of higher quality, safer, and more efficient healthcare often feels like navigating a dense fog without a compass, leaving leaders to question if a clear path to systemic excellence truly exists. As healthcare organizations grapple with unprecedented complexity, the demand

AI in UK Health: Can Innovation and Privacy Coexist?
Data and Information AI in UK Health: Can Innovation and Privacy Coexist?

A patient's medical file, once a collection of paper notes locked in a cabinet, now exists as a vast digital footprint, holding the potential to either revolutionize their care or expose their most sensitive information. This digital transformation places the United Kingdom's National

Who Controls Patient Data: Epic or Its Customers?
Data and Information Who Controls Patient Data: Epic or Its Customers?

The vast digital archives holding the most intimate details of a person's health have become the battleground for a high-stakes legal confrontation that questions the very foundation of data ownership in modern medicine. When a state's attorney general accuses the nation's largest

FDA Updates Dosing Guidance for Inhaled Insulin Afrezza
Public Policy FDA Updates Dosing Guidance for Inhaled Insulin Afrezza

Transitioning from one form of insulin therapy to another has often presented a delicate balancing act, requiring careful calibration to maintain glycemic stability. For adults with diabetes considering a needle-free option, the initial dosing has been a critical hurdle. Now, a landmark revision to

Loading

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later